Skip to main content
Premium Trial:

Request an Annual Quote

Stéphane Bancel, Harry Wilcox

BG Medicine announced Stéphane Bancel has resigned from its board and has been replaced by Harry Wilcox. Bancel and Wilcox are affiliated with Flagship Ventures, a shareholder in BG Medicine. Wilcox has been COO and general partner at Flagship since 2013. Before that, he was CFO and a partner at the venture capital firm. Prior to joining Flagship, he served as CFO and senior vice president of corporate development at Exact Sciences.